Effects of morphine-3-glucuronide and morphine on the K+-evoked release of [3H]-glutamic acid and [14C]-gamma-aminobutyric acid from rat brain synaptosomes-Reference-Cited by-同舟云学术

Effects of morphine-3-glucuronide and morphine on the K+-evoked release of [3H]-glutamic acid and [14C]-gamma-aminobutyric acid from rat brain synaptosomes

Published:1995-12 Issue:5 Volume:58 Page:447-454
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Bartlett Selena E.,Smith Maree T.

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference23 articles.

1. Modulation of GABA release by α-amino-3-hydroxy-5-methylisoxazole-4-propionate and N-methyl-d-aspartate receptors in matrix-enriched areas of the rat striatum

2. Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity

3. High Doses of Spinal Morphine Produce a Nonopiate Receptormediated Hyperesthesia

4. Morphine-3-glucuronide - a potent antagonist of morphine analgesia

5. The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Morphine-3-Glucuronide, Physiology and Behavior;Frontiers in Molecular Neuroscience;2022-05-12

2. Comparative studies of the neuro-excitatory behavioural effects of morphine-3-glucuronide and dynorphin A(2-17) following spinal and supraspinal routes of administration;Pharmacology Biochemistry and Behavior;2009-10

3. Is morphine-3-glucuronide of therapeutic relevance?;Pain;2005-08

4. Morphine inhibits glutamate exocytosis from rat cerebral cortex nerve terminals (synaptosomes) by reducing Ca2+ influx;Synapse;2003

5. Morphine-3β-d-glucuronide Suppresses Inhibitory Synaptic Transmission in Rat Substantia Gelatinosa;Journal of Pharmacology and Experimental Therapeutics;2002-08-01